Please ensure Javascript is enabled for purposes of website accessibility

CRISPR Therapeutics(CRSP)

Nasdaq Global Market

CRSP
CRISPR Therapeutics Stock Quote
$78.87 $3.74 5.0%
Price as of August 10, 2022, 4:00 p.m. ET View Interactive CRSP Charts

CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.

Interactive Chart


Compare CRSP Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
CRSP
CRISPR Therapeutics
$78.87 $6B -45.5% 322.1%
ILMN
$227.30 $34B -57.6% 10.4%
BMY
$74.86 $160B 14.8% 54.0%
EXEL
$19.50 $7B 20.0% -20.4%
GILD
$63.14 $78B -5.2% 3.0%

News & Analysis: CRISPR Therapeutics

The Fool has written over 200 articles on CRISPR Therapeutics.

All

Market Moves

Podcasts











Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.